NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»21/03/2010 [Industry news]
Sinovac Finds India Partner for H1N1 Vaccine

Sinovac Biotech Co. has signed up Parenteral Drugs India to distribute its H1N1 Influenza Vaccine (Split Virion) and Inactivated (Panflu.1) in India. Parenteral, which will have an exclusive license for the vaccines in India, will presumably be responsible for registering them in its home territory.

 
Sinovac Biotech Co. has signed up Parenteral Drugs India to distribute its H1N1 Influenza Vaccine (Split Virion) and Inactivated (Panflu.1) in India. Parenteral, which will have an exclusive license for the vaccines in India, will presumably be responsible for registering them in its home territory. No financial details of the agreement were disclosed. Parenteral produces a long list of pharmaceutical products, including antibiotics, anti-ulcerant, anti- bacterial, anti-inflammatory/analgesics, anti-cold, multi-vitamins and cardiac drugs. It has also recently launched liquid cough syrups, anti-cold medications and other pediatric products. The company is listed on the Bombay exchange. To date, most of Sinovacā€™s revenues have come from within China, though it also registered Panflu.1 in Mexico. Sinovac made its reputation by developing a vaccine for hepatitis B, HealiveĀ®. The company had difficulty gaining market share for its flu vaccine until this year, when it prospered by selling both seasonal flu vaccine and H1N1 vaccine to municipal and provincial health agencies in China. The company has not yet released its 2009 financial results, though analysts expect a large increase in revenues during the last six months of the year.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.